Access Statistics for Lionel Perrier

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Decision-making Tool for a Costly Innovative Technology: The Case of Carbon Ion Radiotherapy 0 0 0 0 1 1 2 24
A cost analysis of complex radiotherapy for patients with head and neck cancer 0 0 0 0 1 1 2 21
A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial 0 0 0 0 0 2 2 16
A cost-analysis of stereotactic radiotherapy in lung cancer 0 0 0 0 0 0 1 14
A cost-consequence analysis of hepatitis B screening in an immigrant population 0 0 0 0 1 1 1 13
A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial 0 0 0 0 1 3 13 24
A cost-effectiveness analysis of the ZIRA test in breast cancer 0 0 0 0 0 0 1 12
A literature review to identify factors that determine policies for influenza vaccination 0 0 0 0 1 1 2 13
A model to calculate treatment cost per protocol for light ion facility radiotherapy projects in Europe 0 0 0 0 0 0 0 4
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) 0 0 0 0 0 0 2 12
Adherence to practice guidelines for the management of patients with sarcoma: A cost-effectiveness assessment in two European regions 0 0 0 0 2 2 3 13
Analyse des corrélations entre informatisation et performance des établissements de santé 0 0 0 0 1 1 7 12
Apports de l'évaluation médico-économique pour la décision publique en santé 0 0 0 0 2 2 3 12
Apports de l'évaluation économique et de l'analyse d'impact budgétaire pour la décision publique en santé: l'exemple du cancer du sein 0 0 0 0 0 0 1 9
Assessing the generalisability of cost evaluation results using the euclidean metric and principal components analysis: Lesson from a high-cost innovation in oncology 0 0 0 0 0 0 0 1
Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients 0 0 2 11 2 2 6 11
Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France 0 0 0 13 0 1 6 16
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis 0 0 0 0 1 1 2 6
Cluster analysis and principal component analysis to access the variability of data in cost evaluations: methods and applications in oncology 0 0 0 0 0 0 0 12
Comprendre les analyses médico-économiques: intervention didactique à l'intention des cliniciens 0 0 0 0 0 0 1 10
Conformity with clinical practice guidelines for management of patients with sarcoma: a cost-effectiveness assessment in two European regions 0 0 0 0 2 2 3 12
Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing 0 0 0 0 0 0 0 6
Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing 0 0 0 0 0 0 3 19
Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection 0 0 0 0 0 0 0 7
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis 0 0 0 0 0 0 0 2
Cost of cancer diagnosis using Next-Generation Sequencing targeted gene panels in routine practice: a nationwide French study 0 0 0 0 2 2 10 92
Cost of physical activity intervention during adjuvant chemotherapy in breast cancer: results of the randomized trial PASAPAS 0 0 0 0 0 0 1 7
Cost of prostate image-guided radiation therapy: Results of a randomized trial 0 0 0 0 0 2 3 8
Cost of radiotherapy: what is the quality of the evidence found? Critical quality appraisal of studies estimating cost of radiotherapy 0 0 0 0 1 1 1 5
Cost-Effectiveness Of Treatments For Mild-To-Moderate Obstructive Sleep Apnea In France 0 0 0 18 1 1 6 31
Cost-effectiveness analysis of compliance with clinical guidelines for sarcoma management 0 0 0 0 0 0 1 6
Cost-effectiveness analysis: an interdisciplinary research and methodological perspective 0 0 0 0 0 0 1 15
Cost-effectiveness analysis: methods and applications in oncology 0 0 0 0 0 0 3 8
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma 0 0 0 0 0 0 2 6
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma 0 0 0 0 2 2 5 14
Cost-effectiveness of a Genetic Test for Breast Cancer Risk - Letter 0 0 0 0 0 0 0 5
Costi del tratamento 0 0 0 0 2 2 3 5
Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment 0 0 0 0 0 0 3 20
Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France 0 0 0 9 1 1 6 27
Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France 0 1 2 16 1 2 9 22
Curiethérapie: valorisation et aspects médico-économiques 0 0 0 0 0 0 2 3
Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study 0 0 0 0 0 0 2 13
Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands 0 0 0 0 0 0 1 7
Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS 0 0 0 0 0 0 1 16
Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study 0 0 0 0 1 1 3 9
Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study 0 0 0 0 1 1 7 15
Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study 0 0 0 0 1 1 2 3
Does adoption of electronic heath record improve the quality of care management? 0 0 0 0 1 2 3 6
Does adoption of electronic records improve organizational performances of hospital surgical units? 0 0 0 0 1 1 1 3
Dossier Patient Informatisé: quel impact sur la performance des établissements de santé en France ? 0 0 0 0 1 1 4 36
Economic burden of seasonal influenza B in France during winter 2010-2011 0 0 0 0 0 0 0 5
Economic burden of seasonal influenza B in France during winter 2010-2011 0 0 0 0 0 0 1 13
Economic burden of seasonal influenza B in France during winter 2010-2011 0 0 0 0 1 1 1 13
Evaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses 0 0 0 0 0 0 2 14
General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France 0 0 0 0 0 0 1 3
Guide méthodologique sur le calcul et l’analyse des coûts hospitaliers 0 0 0 0 2 2 4 15
Guide méthodologique sur le costing à l’Hôpital 0 0 0 0 0 0 0 7
Health Information System Adoption And Hospital Accreditation Decisions In France: Results From The E-SI (PREPS-SIPS) Study 0 0 0 0 1 2 2 17
ISO 9001 certification of innovation and clinical research departments: Extending the scope of health assessment 0 0 0 0 2 2 3 15
Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study 0 0 0 0 0 0 0 13
Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study 0 0 0 0 1 1 2 11
Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach 0 0 0 0 0 0 4 8
Impact of health information systems on hospital bed occupancy rates in French hospitals: results from the e-SI (PREPS-SIPS) study 0 0 0 0 1 1 1 3
In Reply to Escande et al 0 0 0 0 1 1 2 4
In Reply to Fodor and Di Muzio 0 0 0 0 1 1 1 3
In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin 0 0 0 0 0 0 1 7
In reply to Tallet et al 0 0 0 0 0 0 1 2
Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants 0 0 0 0 0 0 3 9
Inégalités d'exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France 0 0 1 1 3 3 16 28
Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France 0 0 0 0 0 0 0 5
Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel: SUMER 2010 0 0 0 0 0 0 1 13
Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel: les enseignements de l'enquête SUMER 0 0 0 0 1 1 5 9
Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel: les enseignements de l’enquête SUMER 0 0 0 0 0 0 2 11
Inégalités d’exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France 0 0 0 3 1 2 9 34
Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study 0 0 0 0 0 0 4 13
Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles l'apanage des emplois précaires et peu qualifiés ? 0 0 0 0 0 0 0 8
Les impacts médico-économiques de l'évolution du parcours de soins en cancérologie 0 0 0 0 1 1 2 16
Les évaluations de coûts en santé sont-elles transférables ? 0 0 0 16 0 0 0 82
Les évaluations de coûts en santé sont-elles transférables ? 0 0 0 2 0 0 3 87
Les évaluations de coûts en santé sont-elles transférables ? Mesures et application à une innovation très coûteuse en cancérologie 0 0 0 0 0 0 0 4
Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol 0 0 0 0 0 0 3 9
Literature review of the decision-making determinants related to the influenza vaccination policy 0 0 0 19 0 0 5 122
Literature review of the decision-­‐making determinants related to the influenza vaccination policy 0 0 1 7 0 0 2 26
Literature review of the decision‐making determinants related to the influenza vaccination policy 0 0 0 0 1 1 1 4
Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units 0 0 0 0 1 2 3 5
Organisation et financement des soins: vers une inadéquation croissante ? 0 0 0 0 0 0 0 5
Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized controlled trial 0 0 0 0 2 2 3 22
Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure 0 0 0 0 1 2 3 8
Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation 0 0 0 0 0 0 6 12
Radiotherapy costs: the good, the bad and the ugly 0 0 0 0 1 1 2 4
Relationship between the development of electronic health records and hospital accreditation decisions in France: results from the E-SI (Preps-Sips) 0 0 0 0 1 1 1 11
Report of work package 6 “Health economics aspects” 0 0 0 0 0 0 0 4
Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment 0 0 0 0 1 1 5 17
Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment 0 0 0 9 0 0 3 307
Système d'information et performance hospitalière 0 0 0 0 0 0 0 22
The contribution of the simulation for innovative technologies: The case of the hadrontherapy 0 0 0 0 0 0 0 1
The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer 0 0 0 15 0 0 8 92
The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer 0 0 0 0 0 3 10 24
The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia 0 0 0 0 0 0 1 14
The use of economic evaluations in health decision-making at the macro level: a literature review 0 0 0 0 0 0 0 9
Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer 0 0 0 0 0 0 0 12
Toxicité et qualité de vie comparées après curiethérapie par iode 125 et radiothérapie stéréotaxique des cancers prostatiques [Toxicity and quality of life comparison of iodine 125 brachytherapy and stereotactic radiotherapy for prostate cancers] 0 0 0 0 1 3 6 8
Trajectoires optimales des patients évoluant vers la dépendance 0 0 0 0 0 0 0 2
Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool 0 0 0 0 0 1 1 12
Transférabilité des évaluations de coûts en santé: analyse des facteurs de variabilité 0 0 0 0 1 1 2 6
Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10 0 0 0 0 1 1 2 6
Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France 0 0 0 0 1 1 4 10
Vers une nécessaire harmonisation des évaluations de coûts en santé. L'exemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France 0 0 0 0 1 1 2 3
What Underlies The Observed Hospital Volume-Outcome Relationship? 0 0 0 0 1 2 2 8
Why should we focus on a structured model of secure digital exchanges to incorporate new documents in electronic patient records? 0 0 0 0 0 0 0 3
Total Working Papers 0 1 6 139 61 81 287 1,943


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A literature review to identify factors that determine policies for influenza vaccination 0 0 0 1 0 0 0 13
Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma 0 0 0 8 1 1 4 50
Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants 0 0 0 1 0 0 1 9
Transférabilité des évaluations de coûts en santé. Analyse des facteurs de variabilité 0 0 0 8 0 0 1 49
Total Journal Articles 0 0 0 18 1 1 6 121


Statistics updated 2019-11-03